IVIG IS OUR MIDDLE NAME
Live / Applied — Fourth extension granted (statement of use) (as of 30 Sept 2025)
What this means for you
Not registered yet, but its 02 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97819809
- Mark type
- Stylized text
- Filed
- 02 Mar 2023
- Published for opposition
- 05 Sept 2023
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 016 — Paper goods and printed matter: Printed materials, namely, newsletters, articles and case studies featuring immunoglobulin, immunodeficiency and neurological disorders; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of immunoglobulin, immunodeficiency and neurological disorders; printed educational materials in the field of immunoglobulin, immunodeficiency and neurological disorders
- Class 035 — Advertising and business services: Healthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals
- Class 041 — Education and entertainment services: Healthcare education services, namely, conducting educational programs for patients, caregivers and/or healthcare professionals concerning immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; planning and conducting educational conventions and educational meetings related to immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
- Class 044 — Medical, beauty and agricultural services: Providing a website featuring healthcare information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders
Owner
- CSL Behring AG, Bern, CH
- CSL Behring AG, Bern, CH
Prosecution history
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2025 — SOU EXTENSION 4 GRANTED
- 30 Sept 2025 — SOU EXTENSION 4 FILED
- 30 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2025 — SOU EXTENSION 3 GRANTED
- 31 Mar 2025 — SOU EXTENSION 3 FILED
- 31 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2024 — SOU EXTENSION 2 GRANTED
- 24 Oct 2024 — SOU EXTENSION 2 FILED
- 24 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2024 — SOU EXTENSION 1 GRANTED